Sitagliptin in diabetes management: a comprehensive review of therapeutic advantages, formulation challenges, and analytical strategies for oral solution development
Sitagliptin is a selective dipeptidyl peptidase-4 (DPP-4) inhibitor that has emerged as a mainstay in the treatment of type 2 diabetes mellitus (T2DM) on account of favourable efficacy, safety and tolerability profile. In this comprehensive review, we discuss the therapeutic advantages of sitagliptin, including its glu...